JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 12.36% |
| 3 | Healthcare | 9.31% |
| 4 | Consumer Discretionary | 8.69% |
| 5 | Industrials | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTLT
3651
CALL
DELISTED
CATALENT, INC.
CTLT
| $1.1M | ﹤0.01% |
20,400
-9,800
| -32% | -$449K |
|
3652
Intrepid Potash
IPI
$493M
| $1.1M | ﹤0.01% |
33,641
-3,257
| -9% | -$114K |
|
3653
PUT
CVS Health
CVS
$124B
| $1.09M | ﹤0.01% |
20,000
| – | – |
|
|
HAPN
3654
Happen Inc
HAPN
$2.26B
| $1.09M | ﹤0.01% |
73,777
+58,175
| +373% | +$918K |
|
3655
Vicor
VICR
$10.8B
| $1.09M | ﹤0.01% |
37,375
+32,054
| +602% | +$1.03M |
|
3656
Surgery Partners
SGRY
$1.97B
| $1.09M | ﹤0.01% |
137,727
-238,152
| -63% | -$2.37M |
|
3657
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
$525M
| $1.09M | ﹤0.01% |
20,778
-1,082
| -5% | -$56.3K |
|
|
EVRI
3658
DELISTED
Everi Holdings
EVRI
| $1.09M | ﹤0.01% |
91,868
-189,453
| -67% | -$2.06M |
|
3659
TriplePoint Venture Growth BDC
TPVG
$221M
| $1.09M | ﹤0.01% |
76,601
-37,049
| -33% | -$519K |
|
3660
Varonis Systems
VRNS
$5.17B
| $1.09M | ﹤0.01% |
54,306
+6,210
| +13% | +$133K |
|
3661
BioCryst Pharmaceuticals
BCRX
$2.49B
| $1.08M | ﹤0.01% |
298,597
-19,532
| -6% | -$118K |
|
|
VNET
3662
VNET Group
VNET
$2.16B
| $1.08M | ﹤0.01% |
137,277
+77,374
| +129% | +$592K |
|
3663
PUT
Dollar Tree
DLTR
$24.9B
| $1.08M | ﹤0.01% |
10,000
-22,300
| -69% | -$2.35M |
|
|
PRTK
3664
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $1.08M | ﹤0.01% |
280,228
-18,586
| -6% | -$88.4K |
|
3665
Sutro Biopharma
STRO
$340M
| $1.08M | ﹤0.01% |
9,504
-82
| -0.9% | -$9.04K |
|
3666
iShares Mortgage Real Estate ETF
REM
$546M
| $1.08M | ﹤0.01% |
25,712
-13,695
| -35% | -$588K |
|
3667
Resources Connection
RGP
$145M
| $1.07M | ﹤0.01% |
68,439
-17,470
| -20% | -$278K |
|
3668
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.38B
| $1.07M | ﹤0.01% |
11,678
-242
| -2% | -$21.8K |
|
3669
PUT
Air Products & Chemicals
APD
$68.8B
| $1.07M | ﹤0.01% |
4,800
-5,100
| -52% | -$1.06M |
|
3670
PUT
NOV
NOV
$7.54B
| $1.07M | ﹤0.01% |
50,000
| – | – |
|
|
AVLR
3671
PUT
DELISTED
Avalara, Inc.
AVLR
| $1.07M | ﹤0.01% |
+15,100
| New | +$975K |
|
|
NRE
3672
DELISTED
NorthStar Realty Europe Corp.
NRE
| $1.07M | ﹤0.01% |
65,668
+11,877
| +22% | +$201K |
|
3673
Farmers National Banc Corp
FMNB
$966M
| $1.07M | ﹤0.01% |
74,934
-1,848
| -2% | -$26.3K |
|
3674
CALL
MGM Resorts International
MGM
$11.1B
| $1.06M | ﹤0.01% |
37,400
-553,700
| -94% | -$14.8M |
|
3675
Old Second Bancorp
OSBC
$1.32B
| $1.06M | ﹤0.01% |
83,767
-2,018
| -2% | -$25.9K |
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,669 increased, 2,117 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.